Novo Nordisk A/S
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public
- Established
- 1923-01-01
- Employees
- 63.3K
- Market Cap
- $602.2B
- Website
- http://www.novonordisk.com
A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 1200000
- Registration Number
- NCT06741111
- Locations
- 🇮🇳
Novo Nordisk Investigational Site, Bangalore, India
A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-17
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 100
- Registration Number
- NCT06737536
- Locations
- 🇺🇸
Celerion, Lincoln, Lincoln, Nebraska, United States
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 465
- Registration Number
- NCT06717698
- Locations
- 🇺🇸
N America Res Inst - San Dimas, San Dimas, California, United States
🇺🇸NorCal Endocrinology and Internal Medicine, San Ramon, California, United States
🇺🇸Northeast Research Institute, Saint Augustine, Florida, United States
A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-0130 in Participants With Overweight or Obesity
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 114
- Registration Number
- NCT06718998
- Locations
- 🇦🇹
Clinical Trials Unit / Center for Medical Research, Graz, Austria
A Study on How NNC0174-1213 Works in People With Overweight or Obesity.
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 177
- Registration Number
- NCT06719011
- Locations
- 🇺🇸
ICON Early Phase Services, LLC, Salt Lake City, Utah, United States
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 18
- Registration Number
- NCT06716307
- Locations
- 🇺🇸
Celerion, Lincoln, Lincoln, Nebraska, United States
A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-29
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 500
- Registration Number
- NCT06709040
A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-12
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 154
- Registration Number
- NCT06685185
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
Levels of Inflammation in Middle East People With Cardiovascular Disease With/Without Kidney Disease
- Conditions
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 756
- Registration Number
- NCT06655493
- Locations
- 🇸🇦
Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia
🇸🇦National Guard- Alahsa, Al Ahsa, Saudi Arabia
🇸🇦King Fahad Armed Forces, Jeddah, Jeddah, Saudi Arabia
A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy Men
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 92
- Registration Number
- NCT06649630
- Locations
- 🇩🇪
Charité Research Organisation GmbH, Berlin, Germany
© Copyright 2024. All Rights Reserved by MedPath